26 related articles for article (PubMed ID: 15474668)
1. Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma.
Sahin I; Kawano Y; Sklavenitis-Pistofidis R; Moschetta M; Mishima Y; Manier S; Sacco A; Carrasco R; Fonseca R; Roccaro AM; Witzig T; Ghobrial IM
Blood Adv; 2019 Apr; 3(7):995-1002. PubMed ID: 30940634
[TBL] [Abstract][Full Text] [Related]
2. RhoGDI deficiency induces constitutive activation of Rho GTPases and COX-2 pathways in association with breast cancer progression.
Bozza WP; Zhang Y; Hallett K; Rivera Rosado LA; Zhang B
Oncotarget; 2015 Oct; 6(32):32723-36. PubMed ID: 26416248
[TBL] [Abstract][Full Text] [Related]
3. Reinventing diagnostics for personalized therapy in oncology.
Banerjee D
Cancers (Basel); 2010 Jun; 2(2):1066-91. PubMed ID: 24281107
[TBL] [Abstract][Full Text] [Related]
4. Suppression of KIF14 expression inhibits hepatocellular carcinoma progression and predicts favorable outcome.
Yang T; Zhang XB; Zheng ZM
Cancer Sci; 2013 May; 104(5):552-7. PubMed ID: 23414349
[TBL] [Abstract][Full Text] [Related]
5. Targeting S100P inhibits colon cancer growth and metastasis by Lentivirus-mediated RNA interference and proteomic analysis.
Jiang L; Lai YK; Zhang J; Wang H; Lin MC; He ML; Kung HF
Mol Med; 2011; 17(7-8):709-16. PubMed ID: 21327297
[TBL] [Abstract][Full Text] [Related]
6. Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA.
Ding J; Huang S; Wu S; Zhao Y; Liang L; Yan M; Ge C; Yao J; Chen T; Wan D; Wang H; Gu J; Yao M; Li J; Tu H; He X
Nat Cell Biol; 2010 Apr; 12(4):390-9. PubMed ID: 20305651
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer: developmental networks gone awry?
Dong J; Kislinger T; Jurisica I; Wigle DA
Cancer Biol Ther; 2009 Feb; 8(4):312-8. PubMed ID: 19202349
[TBL] [Abstract][Full Text] [Related]
8. Pituitary tumor-transforming 1 increases cell motility and promotes lymph node metastasis in esophageal squamous cell carcinoma.
Ito T; Shimada Y; Kan T; David S; Cheng Y; Mori Y; Agarwal R; Paun B; Jin Z; Olaru A; Hamilton JP; Yang J; Abraham JM; Meltzer SJ; Sato F
Cancer Res; 2008 May; 68(9):3214-24. PubMed ID: 18451147
[TBL] [Abstract][Full Text] [Related]
9. Understanding prognostic gene expression signatures in lung cancer.
Zhu CQ; Pintilie M; John T; Strumpf D; Shepherd FA; Der SD; Jurisica I; Tsao MS
Clin Lung Cancer; 2009 Sep; 10(5):331-40. PubMed ID: 19808191
[TBL] [Abstract][Full Text] [Related]
10. Genomic prognostic models in early-stage lung cancer.
Kratz JR; Jablons DM
Clin Lung Cancer; 2009 May; 10(3):151-7. PubMed ID: 19443334
[TBL] [Abstract][Full Text] [Related]
11. Validating the prognostic value of marker genes derived from a non-small cell lung cancer microarray study.
Blackhall FH; Wigle DA; Jurisica I; Pintilie M; Liu N; Darling G; Johnston MR; Keshavjee S; Waddell T; Winton T; Shepherd FA; Tsao MS
Lung Cancer; 2004 Nov; 46(2):197-204. PubMed ID: 15474668
[TBL] [Abstract][Full Text] [Related]
12. Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression.
Lee ES; Son DS; Kim SH; Lee J; Jo J; Han J; Kim H; Lee HJ; Choi HY; Jung Y; Park M; Lim YS; Kim K; Shim Y; Kim BC; Lee K; Huh N; Ko C; Park K; Lee JW; Choi YS; Kim J
Clin Cancer Res; 2008 Nov; 14(22):7397-404. PubMed ID: 19010856
[TBL] [Abstract][Full Text] [Related]
13. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
Tsai MF; Wang CC; Chang GC; Chen CY; Chen HY; Cheng CL; Yang YP; Wu CY; Shih FY; Liu CC; Lin HP; Jou YS; Lin SC; Lin CW; Chen WJ; Chan WK; Chen JJ; Yang PC
J Natl Cancer Inst; 2006 Jun; 98(12):825-38. PubMed ID: 16788156
[TBL] [Abstract][Full Text] [Related]
14. Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung.
O-charoenrat P; Rusch V; Talbot SG; Sarkaria I; Viale A; Socci N; Ngai I; Rao P; Singh B
Clin Cancer Res; 2004 Sep; 10(17):5792-803. PubMed ID: 15355908
[TBL] [Abstract][Full Text] [Related]
15. A five-gene signature and clinical outcome in non-small-cell lung cancer.
Chen HY; Yu SL; Chen CH; Chang GC; Chen CY; Yuan A; Cheng CL; Wang CH; Terng HJ; Kao SF; Chan WK; Li HN; Liu CC; Singh S; Chen WJ; Chen JJ; Yang PC
N Engl J Med; 2007 Jan; 356(1):11-20. PubMed ID: 17202451
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
